Fresenius SE & Co. KGaA (FRA:FRE – Get Free Report)’s stock price was up 1.8% during trading on Monday. The company traded as high as €42.73 and last traded at €42.35. Approximately 1,014,166 shares traded hands during mid-day trading, The stock had previously closed at €41.59.
Fresenius SE & Co. KGaA Stock Up 1.8%
The firm has a 50 day moving average of €45.38 and a 200 day moving average of €42.62.
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients.
Further Reading
- Five stocks we like better than Fresenius SE & Co. KGaA
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
- China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
- 3 REITs That May Win in a Higher Interest Rate Environment
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
